FDA Inspection 881586 — Scantibodies Laboratory, Inc.

Scantibodies Laboratory, Inc. — FEI 2020808

The FDA completed an inspection of Scantibodies Laboratory, Inc. on June 16, 2014 in Santee, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 8 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 16, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Santee, CA (United States)

Citations

IDCFRDescription
3121 CFR 606.20(b)Qualifications of responsible personnel
324421 CFR 640.61Written consent
33821 CFR 640.65(b)(2)(i)Physician review of four month sample
34321 CFR 640.65(b)(3)Donor identification system
345521 CFR 601.12(f)(1)Labeling changes
36821 CFR 640.72(d)Donor reaction
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
7821 CFR 606.100(c)Record review prior to release